annual EBITDA:
-$342.21M-$101.72M(-42.30%)Summary
- As of today (May 29, 2025), DYN annual EBITDA is -$342.21 million, with the most recent change of -$101.72 million (-42.30%) on December 31, 2024.
- During the last 3 years, DYN annual EBITDA has fallen by -$193.28 million (-129.77%).
- DYN annual EBITDA is now -7048.80% below its all-time high of -$4.79 million, reached on December 31, 2018.
Performance
DYN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$121.87M-$25.21M(-26.08%)Summary
- As of today (May 29, 2025), DYN quarterly EBITDA is -$121.87 million, with the most recent change of -$25.21 million (-26.08%) on March 31, 2025.
- Over the past year, DYN quarterly EBITDA has dropped by -$53.10 million (-77.21%).
- DYN quarterly EBITDA is now -2218.24% below its all-time high of -$5.26 million, reached on December 31, 2019.
Performance
DYN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$395.31M-$53.10M(-15.52%)Summary
- As of today (May 29, 2025), DYN TTM EBITDA is -$395.31 million, with the most recent change of -$53.10 million (-15.52%) on March 31, 2025.
- Over the past year, DYN TTM EBITDA has dropped by -$131.10 million (-49.62%).
- DYN TTM EBITDA is now -6753.54% below its all-time high of -$5.77 million, reached on September 30, 2019.
Performance
DYN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DYN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.3% | -77.2% | -49.6% |
| 3 y3 years | -129.8% | -244.7% | -148.0% |
| 5 y5 years | -2245.8% | -1487.1% | -2013.5% |
DYN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -129.8% | at low | -244.7% | at low | -148.0% | at low |
| 5 y | 5-year | -2245.8% | at low | -1487.1% | at low | -2013.5% | at low |
| alltime | all time | -7048.8% | at low | -2218.2% | at low | -6753.5% | at low |
DYN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$121.87M(+26.1%) | -$395.31M(+15.5%) |
| Dec 2024 | -$342.21M(+42.3%) | -$96.66M(-8.1%) | -$342.21M(+9.4%) |
| Sep 2024 | - | -$105.22M(+47.0%) | -$312.84M(+16.1%) |
| Jun 2024 | - | -$71.56M(+4.1%) | -$269.46M(+2.0%) |
| Mar 2024 | - | -$68.77M(+2.2%) | -$264.21M(+9.9%) |
| Dec 2023 | -$240.49M(+42.1%) | -$67.29M(+8.8%) | -$240.49M(+12.9%) |
| Sep 2023 | - | -$61.84M(-6.7%) | -$212.94M(+10.3%) |
| Jun 2023 | - | -$66.31M(+47.2%) | -$192.98M(+7.8%) |
| Mar 2023 | - | -$45.05M(+13.4%) | -$178.97M(+5.7%) |
| Dec 2022 | -$169.28M | -$39.74M(-5.1%) | -$169.28M(-6.6%) |
| Sep 2022 | - | -$41.88M(-19.9%) | -$181.15M(-0.3%) |
| Jun 2022 | - | -$52.30M(+47.9%) | -$181.78M(+14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$35.36M(-31.5%) | -$159.40M(+7.0%) |
| Dec 2021 | -$148.94M(+155.3%) | -$51.62M(+21.4%) | -$148.94M(+18.5%) |
| Sep 2021 | - | -$42.51M(+42.1%) | -$125.67M(+29.9%) |
| Jun 2021 | - | -$29.92M(+20.2%) | -$96.78M(+28.1%) |
| Mar 2021 | - | -$24.90M(-12.2%) | -$75.56M(+29.5%) |
| Dec 2020 | -$58.34M(+299.9%) | -$28.35M(+108.2%) | -$58.34M(+65.5%) |
| Sep 2020 | - | -$13.62M(+56.5%) | -$35.25M(+28.6%) |
| Jun 2020 | - | -$8.70M(+13.3%) | -$27.40M(+46.5%) |
| Mar 2020 | - | -$7.68M(+46.1%) | -$18.70M(+69.7%) |
| Dec 2019 | -$14.59M(+204.7%) | -$5.26M(-8.9%) | -$11.03M(+91.1%) |
| Sep 2019 | - | -$5.77M | -$5.77M |
| Dec 2018 | -$4.79M | - | - |
FAQ
- What is Dyne Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Dyne Therapeutics?
- What is Dyne Therapeutics annual EBITDA year-on-year change?
- What is Dyne Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly EBITDA year-on-year change?
- What is Dyne Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Dyne Therapeutics?
- What is Dyne Therapeutics TTM EBITDA year-on-year change?
What is Dyne Therapeutics annual EBITDA?
The current annual EBITDA of DYN is -$342.21M
What is the all time high annual EBITDA for Dyne Therapeutics?
Dyne Therapeutics all-time high annual EBITDA is -$4.79M
What is Dyne Therapeutics annual EBITDA year-on-year change?
Over the past year, DYN annual EBITDA has changed by -$101.72M (-42.30%)
What is Dyne Therapeutics quarterly EBITDA?
The current quarterly EBITDA of DYN is -$121.87M
What is the all time high quarterly EBITDA for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly EBITDA is -$5.26M
What is Dyne Therapeutics quarterly EBITDA year-on-year change?
Over the past year, DYN quarterly EBITDA has changed by -$53.10M (-77.21%)
What is Dyne Therapeutics TTM EBITDA?
The current TTM EBITDA of DYN is -$395.31M
What is the all time high TTM EBITDA for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM EBITDA is -$5.77M
What is Dyne Therapeutics TTM EBITDA year-on-year change?
Over the past year, DYN TTM EBITDA has changed by -$131.10M (-49.62%)